Dirnhofer S - Search Results

1

[Classification of aggressive B-cell lymphomas : News and open questions].

Rosenwald A, Menter T, Dirnhofer S. Rosenwald A, et al. Among authors: dirnhofer s. Pathologie (Heidelb). 2023 May;44(3):166-172. doi: 10.1007/s00292-023-01187-4. Epub 2023 Mar 14. Pathologie (Heidelb). 2023. PMID: 36918411 Free PMC article. Review. German.

2

B-cell lymphomas with discordance between pathological features and clinical behavior.

de Leval L, Copie-Bergman C, Rosenwald A, Rimsza L, Pittaluga S, Bisig B, Dirnhofer S, Facchetti F, Pileri S, Fend F, Wotherspoon A. de Leval L, et al. Among authors: dirnhofer s. Virchows Arch. 2017 Oct;471(4):439-451. doi: 10.1007/s00428-017-2152-9. Epub 2017 Jun 1. Virchows Arch. 2017. PMID: 28573510 Free article.

3

Beneficial role of increased FOXP3⁺ regulatory T-cells in acute myeloid leukaemia therapy response.

Menter T, Kuzmanic B, Bucher C, Medinger M, Halter J, Dirnhofer S, Tzankov A. Menter T, et al. Among authors: dirnhofer s. Br J Haematol. 2018 Aug;182(4):581-583. doi: 10.1111/bjh.14819. Epub 2017 Jun 27. Br J Haematol. 2018. PMID: 28653378 Free article. No abstract available.

4

Lymphomdiagnostik durch den Pathologen – von der Morphologie über den Immunphänotyp bis zur Genanalyse.

Menter T, Tzankov A, Dirnhofer S. Menter T, et al. Among authors: dirnhofer s. Ther Umsch. 2017 Sep;74(4):197-203. doi: 10.1024/0040-5930/a000904. Ther Umsch. 2017. PMID: 28950777 Review. German. No abstract available.

5

RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic Pitfall.

Menter T, Lundberg P, Wenzel F, Dirks J, Fernandez P, Friess D, Dirnhofer S, Tzankov A. Menter T, et al. Among authors: dirnhofer s. Pathobiology. 2019;86(2-3):162-166. doi: 10.1159/000493688. Epub 2018 Nov 5. Pathobiology. 2019. PMID: 30396184 Free article.

6

ALK-negative anaplastic large cell lymphoma arising in the thrombus of an aortic prosthesis preceeded by clonally related lymphomatoid papulosis.

Menter T, Ballova V, Caspar C, Wolff T, Kasenda B, Singer G, Juskevicius D, Tzankov A, Dirnhofer S. Menter T, et al. Among authors: dirnhofer s. Virchows Arch. 2019 Jun;474(6):763-767. doi: 10.1007/s00428-019-02531-x. Epub 2019 Jan 26. Virchows Arch. 2019. PMID: 30685783

7

Transformation of a splenic marginal zone lymphoma into classic Hodgkin lymphoma.

Menter T, Dirnhofer S, Tzankov A. Menter T, et al. Among authors: dirnhofer s. J Clin Pathol. 2019 May;72(5):391-392. doi: 10.1136/jclinpath-2018-205678. Epub 2019 Feb 27. J Clin Pathol. 2019. PMID: 30814198 No abstract available.

8

[Reactive Lymphadenopathies].

Vallejo A, Menter T, Tzankov A, Dirnhofer S. Vallejo A, et al. Among authors: dirnhofer s. Ther Umsch. 2019;76(7):365-373. doi: 10.1024/0040-5930/a001111. Ther Umsch. 2019. PMID: 31913097 Review. German.

9

Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy.

Menter T, Tzankov A, Zucca E, Kimby E, Hultdin M, Sundström C, Beiske K, Cogliatti S, Banz Y, Cathomas G, Karjalainen-Lindsberg ML, Grobholz R, Mazzucchelli L, Sander B, Hawle H, Hayoz S, Dirnhofer S. Menter T, et al. Among authors: dirnhofer s. Br J Haematol. 2020 May;189(4):707-717. doi: 10.1111/bjh.16414. Epub 2020 Feb 3. Br J Haematol. 2020. PMID: 32012230 Free article.

10

Immunomodulatory drugs may overcome the negative prognostic role of active Th17 axis in follicular lymphoma: evidence from the SAKK35/10 trial.

Menter T, Hayoz S, Zucca E, Kimby E, Dirnhofer S, Tzankov A. Menter T, et al. Among authors: dirnhofer s. Br J Haematol. 2020 Aug;190(4):e258-e261. doi: 10.1111/bjh.16876. Epub 2020 Jun 11. Br J Haematol. 2020. PMID: 32525232 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page